Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases

Pediatric Infectious Disease Journal

Volumn 16, Issue 5, 1997, Pages 479-481

  Kimpen, Jan L L ^a   Schaad, Urs B ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Bronchiolitis; corticosteroids; respiratory syncytial virus; ribavirin; treatment

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; RIBAVIRIN;

ARTICLE; BRONCHIOLITIS; EUROPE; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT PLANNING;

ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; COMMUNICABLE DISEASES; HUMANS; INFANT; POLICY MAKING; POPULATION SURVEILLANCE; PROGRAM EVALUATION; QUESTIONNAIRES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN;

EID: 0030908152     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199705000-00004     Document Type: Article

References (15)

1. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973;288:498-505.
2. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993;23:50-79.
3. Collins PL, McIntosh K, Chanock RM. Respiratory syncytial virus. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields virology. 3rd ed. vol. 1. Philadelphia: Lippincott-Raven, 1996: 1313-51.
4. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J 1982;284:1665-9.
5. Kimpen JLL, Heymans HSA. Respiratory syncytial virus: immunity and immune injury. Immunol Infect Dis 1993;3: 281-8.
6. Chanock RM, Parrott RH, Connors M, Collins PL, Murphy BR. Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. Pediatrics 1992;90:137-43.
7. Wald ER, Dashefsky B, Green M. In re ribavirin: a case of premature adjucation? J Pediatr 1988;112:154-8.
8. Kimpen JLL. Treatment of respiratory syncytial virus bronchiolitis: hope and despair. In: Tibboel D, van der Voort E, eds. Intensive care in childhood: a challenge to the future. Heidelberg: Springer-Verlag, 1996:354-61.
9. McGowan JE Jr, Chesney PJ, Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J Infect Dis 1992;165:1-13.
10. Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. In: Peter G, ed. Report of the Committee on Infectious Diseases (Red Book). 23rd ed. Elk Grove Village, IL: American Academy of Pediatrics, 1994:570-4.
11. Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996;97:137-40.
12. Wald ER, Dashefsky B. Ribavirin. Red Book Committee recommendations questioned. Pediatrics 1994;93:672-3.
13. Pope JF, Besunder JB, Kumar ML, Super DM. Concerned about ribavirin recommendations. Pediatrics 1994;94:132-3.
14. Feldstein TJ, Swegarden JL, Atwood GF, Peterson CD. Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy. Pediatrics 1995;96:14-7.
15. Word BM, Klein JO. Therapy of bacterial sepsis and meningitis in infants and children: 1989 poll of directors of programs in pediatric infectious diseases. Pediatr Infect Dis J 1989;8:635-7.